当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Significance of Cervical Malignant Growth in Pregnant Ladies on the Survival of Women with Early-Stage Cervical Cancer

Thoru Pederson

As of late, the rate of gynecological threatening growths during pregnancy has expanded, essentially because of the expanded number of advanced age pregnancy. The most widely recognized gynecological threatening growths in pregnancy are cervical disease, representing 71.6%, trailed by ovarian harmful cancers, representing 7.0%. The frequency of cervical malignant growth in pregnancy is itself not exceptionally high, and the side effects are effectively mistaken for different sicknesses in pregnancy. During pregnancy, gynecological assessment is restricted, and consequently, the pace of misdiagnosis is higher. The therapy of cervical malignant growth during pregnancy is connected with many elements, for example, cancer size, obsessive sort, time of development, lymph hub association, and patients' ability to keep up with pregnancy. As an explanation of these variables, deciding the ideal treatment is troublesome. This article surveys the examination progress on the conclusion and therapy standards of cervical disease in pregnancy, to figure out some kind of harmony between powerful treatment of cancers and assurance of fetal wellbeing and stay away from defers in therapy and preterm conveyance.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。